Is Cystic Fibrosis Carrier Screening Cost Effective?

Publisher： Karger

E-ISSN： 1662-8063|10|2|103-109

ISSN： 1662-4246

Source： Public Health Genomics, Vol.10, Iss.2, 2007-03, pp. : 103-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessing the Potential Success of Cystic Fibrosis Carrier Screening: Lessons Learned from Tay-Sachs Disease and β-Thalassemia

By  

Public Health Genomics, Vol. 13, Iss. 5, 2009-10 ,pp. : 310-319

Karger

Access to resources Recommend Favorite

How Should Preconceptional Cystic Fibrosis Carrier Screening Be Provided? Opinions of Potential Providers and the Target Population

By  

Public Health Genomics, Vol. 6, Iss. 3, 2004-06 ,pp. : 157-165

Karger

Access to resources Recommend Favorite

Offering Preconceptional Cystic Fibrosis Carrier Couple Screening in the Absence of Established Preconceptional Care Services

By  

Public Health Genomics, Vol. 6, Iss. 1, 2003-04 ,pp. : 5-13

Karger

Access to resources Recommend Favorite

Uptake and Impact of Carrier Testing for Cystic Fibrosis

By  

Public Health Genomics, Vol. 1, Iss. 1, 1998-05 ,pp. : 23-35

Karger

Access to resources Recommend Favorite

Cystic fibrosis: A look into the future of prenatal screening and therapy

By  

Birth Defects Research. Part C: Embryo Today Reviews, Vol. 105, Iss. 1, 2015-03 ,pp. : 73-80

John Wiley & Sons Inc

Access to resources Recommend Favorite